Updating results

1 result

Sort: Relevance | Date

Atezolizumab with nab-paclitaxel for treating PD L1-positive, triple-negative, advanced breast cancer [ID1522]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 24 October 2019.

Technology appraisal guidance In consultation